Decibel Therapeutics, Inc. DBTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour Decibel Therapeutics, Inc. (DBTX), dont 23 achats et 20 ventes. Le total des achats d'initiés s'élève à $3.3M et le total des ventes d'initiés à $6.91M.

Les initiés notables ayant une activité récente comprennent Mclaughlin Kevin F, Reid Laurence, Kapusta Matthew C. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — DBTX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-09-25	Mclaughlin Kevin F	Director	Restitution d'Actions	5,000	$4.78	$23.9K	-
2023-09-25	Reid Laurence	See Remarks	Restitution d'Actions	1,072,539	$4.40	$4.72M	-
2023-09-25	Kapusta Matthew C	Director	Restitution d'Actions	10,000	$3.34	$33.4K	-
2023-09-25	Finger Alison Cecily	Director	Restitution d'Actions	20,000	$6.20	$124K	-
2023-09-25	Carson William H.	Director	Restitution d'Actions	20,000	$8.42	$168.4K	-
2023-09-25	Trask Anna	Chief People Officer	Restitution d'Actions	137,302	$4.40	$604.13K	-
2023-09-25	Lee John Jui-jen	Chief Development Officer	Restitution d'Actions	232,003	$4.40	$1.02M	-
2023-09-25	Nochur Sara	Director	Restitution d'Actions	20,000	$6.20	$124K	-
2023-06-13	Mclaughlin Kevin F	Director	Attribution de RSU	5,000	$4.78	$23.9K	5,000
2023-06-13	Finger Alison Cecily	Director	Attribution de RSU	5,000	$4.78	$23.9K	5,000
2023-06-13	Carson William H.	Director	Attribution de RSU	5,000	$4.78	$23.9K	5,000
2023-06-13	Nochur Sara	Director	Attribution de RSU	5,000	$4.78	$23.9K	5,000
2023-03-19	Kapusta Matthew C	Director	Inconnu	-	-	-	-
2023-03-19	Kapusta Matthew C	Director	Attribution de RSU	10,000	$3.34	$33.4K	10,000
2023-03-16	Reid Laurence	See Remarks	Attribution de RSU	72,000	$3.73	$268.56K	72,000
2023-01-26	Trask Anna	Chief People Officer	Attribution de RSU	45,000	-	-	45,000
2023-01-26	Lee John Jui-jen	Chief Development Officer	Attribution de RSU	45,000	-	-	45,000
2022-10-10	Mclaughlin Kevin F	Director	Inconnu	-	-	-	-
2022-10-10	Mclaughlin Kevin F	Director	Attribution de RSU	20,000	-	-	20,000
2022-10-07	Murphy James B	Officer	Inconnu	-	-	-	-
2022-06-17	Thompson Peter A.	10 Percent Owner	Attribution de RSU	10,000	$2.30	$23K	10,000
2022-06-17	Exter Neil	10 Percent Owner	Attribution de RSU	10,000	$2.30	$23K	10,000
2022-06-17	Finger Alison Cecily	Director	Attribution de RSU	10,000	$2.30	$23K	10,000
2022-06-17	Carson William H.	Director	Attribution de RSU	10,000	$2.30	$23K	10,000
2022-06-17	Nochur Sara	Director	Attribution de RSU	10,000	-	-	10,000
2022-02-25	Reid Laurence	See Remarks	Attribution de RSU	187,500	$3.50	$656.25K	187,500
2022-02-25	Trask Anna	See Remarks	Attribution de RSU	52,500	$3.50	$183.75K	52,500
2022-02-25	Leiderman Elisabeth	Chief Financial Officer	Attribution de RSU	52,500	$3.50	$183.75K	52,500
2022-02-25	Lee John Jui-jen	Chief Development Officer	Attribution de RSU	52,500	$3.50	$183.75K	52,500
2022-01-03	Trask Anna	See Remarks	Vente Informative	377	$5.03	$1.9K	1,864
2021-12-03	Finger Alison Cecily	Director	Inconnu	-	-	-	-
2021-12-03	Finger Alison Cecily	Director	Attribution de RSU	20,000	$6.20	$124K	20,000
2021-12-03	Nochur Sara	Director	Inconnu	-	-	-	-
2021-12-03	Nochur Sara	Director	Attribution de RSU	20,000	$6.20	$124K	20,000
2021-12-02	Trask Anna	See Remarks	Vente Informative	378	$6.34	$2.39K	2,242
2021-11-03	Trask Anna	See Remarks	Vente Informative	378	$8.34	$3.15K	7,533
2021-11-02	Trask Anna	See Remarks	Vente Informative	4,913	$8.31	$40.83K	7,911
2021-10-14	Trask Anna	See Remarks	Vente Informative	5,364	$7.55	$40.48K	12,824
2021-09-15	Reid Laurence	President and Chief Executive	Achat Informatif	10,000	$7.64	$76.4K	25,849
2021-08-16	Hu Cynthia W.	Officer	Inconnu	-	-	-	-
2021-08-16	Hu Cynthia W.	General Counsel	Attribution de RSU	150,000	$7.37	$1.11M	150,000
2021-06-02	Carson William H.	Director	Inconnu	-	-	-	-
2021-06-02	Carson William H.	Director	Attribution de RSU	20,000	$8.42	$168.4K	20,000
2021-02-17	Gv 2016 Gp, L.l.c.	10 Percent Owner	Conversion (Vente)	5,000,000	-	-	-
2021-02-17	Gv 2017 Gp, L.l.c.	10 Percent Owner	Conversion (Vente)	6,250,000	-	-	-
2021-02-17	Gv 2019 Gp, L.l.c.	10 Percent Owner	Conversion (Vente)	4,344,048	-	-	-
2021-02-17	Regeneron Pharmaceuticals, Inc.	10 Percent Owner	Conversion (Vente)	14,000,000	-	-	-
2021-02-17	Longevity Fund 2 Lp	10 Percent Owner	Conversion (Vente)	79,143	-	-	-
2021-02-17	Orbimed Advisors Llc	10 Percent Owner	Conversion (Vente)	1,158,412	-	-	-
2021-02-17	Glaxosmithkline Plc	Director	Conversion (Vente)	1,737,619	-	-	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration